Equities
Health CareMedical Equipment and Services
  • Price (USD)235.05
  • Today's Change1.95 / 0.84%
  • Shares traded181.00
  • 1 Year change+7.89%
  • Beta0.8400
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

  • Revenue in USD (TTM)23.74bn
  • Net income in USD3.93bn
  • Incorporated1986
  • Employees61.00k
  • Location
    Danaher Corp2200 Pennsylvania Ave NW Ste 800WWASHINGTON 20037-1731United StatesUSA
  • Phone+1 (202) 828-0850
  • Fax+1 (202) 828-0860
  • Websitehttps://www.danaher.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medtronic PLC33.00bn4.29bn108.68bn95.00k25.862.2415.613.293.283.2825.1937.810.36642.035.41347,326.304.804.575.475.1465.4666.7513.1013.491.399.820.367780.583.641.16-2.18-4.566.956.65
Boston Scientific Corporation15.91bn1.79bn134.86bn48.00k75.646.5144.618.481.211.2110.7314.050.44121.916.91331,458.304.962.505.852.9169.0968.8411.246.471.026.020.34190.0012.297.71144.55-0.42767.82--
Stryker Corp21.97bn3.59bn148.73bn52.00k41.827.3832.156.779.339.3357.0852.860.53681.566.27422,576.908.776.6010.767.8463.8863.9916.3413.131.22--0.434543.7011.118.5534.229.680.104710.16
Danaher Corp23.74bn3.93bn169.77bn61.00k44.353.3127.457.155.305.2432.0571.030.28213.396.11389,213.104.675.935.196.5659.2658.7916.5719.111.0121.310.254614.33-10.336.98-32.5011.8516.1011.32
Intuitive Surgical, Inc.7.87bn2.24bn196.12bn13.68k88.5112.5971.1124.936.226.2221.8143.750.48481.987.44575,234.0013.9312.4215.6313.8366.9867.6028.7326.313.42--0.000.0014.4913.8535.989.7741.53--
Thermo Fisher Scientific Inc42.37bn6.14bn197.41bn122.00k32.374.0321.004.6615.9515.95110.12128.080.42924.634.32347,295.106.287.797.369.1140.7744.9414.6216.761.2624.080.41836.75-4.5811.96-13.7414.4314.3015.39
Abbott Laboratories41.22bn5.77bn203.38bn114.00k35.555.1122.624.933.303.3023.5722.940.56292.716.08361,552.607.887.729.779.3955.8156.7313.9914.391.1428.440.272354.95-8.125.58-17.4518.369.5712.74
Data as of Nov 22 2024. Currency figures normalised to Danaher Corp's reporting currency: US Dollar USD

Institutional shareholders

30.80%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202456.57m7.83%
BlackRock Fund Advisorsas of 30 Sep 202428.97m4.01%
SSgA Funds Management, Inc.as of 30 Sep 202427.48m3.81%
Wellington Management Co. LLPas of 30 Sep 202422.54m3.12%
T. Rowe Price Associates, Inc. (IM)as of 30 Sep 202419.55m2.71%
Fidelity Management & Research Co. LLCas of 30 Sep 202419.50m2.70%
Capital Research & Management Co. (International Investors)as of 30 Sep 202417.83m2.47%
Geode Capital Management LLCas of 30 Sep 202413.04m1.81%
Norges Bank Investment Managementas of 30 Jun 20249.17m1.27%
T. Rowe Price Investment Management, Inc.as of 30 Sep 20247.82m1.08%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.